---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-006732"
form_type: "8-K"
ticker: null
cik: "0001838821"
company_name: "ARYA Sciences Acquisition Corp IV"
filed_at: "2024-02-09T23:59:59+00:00"
generated_at: "2026-06-06T04:57:36.724289+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ARYA Sciences IV enters $1M convertible promissory note with sponsor for working capital and trust extensions

## Summary
- Up to $1,000,000 non-interest-bearing loan from sponsor ARYA Sciences Holdings IV; draws in increments of $111,000.
- Loans convert at $10.00 per share into Class A ordinary shares identical to private placement shares from the IPO.
- Proceeds used for general corporate purposes and monthly deposits to extend the deadline to complete a business combination.
- If no business combination closes, loan is repaid only from funds outside the trust account; trust account is waived.
- Maturity on business combination closing; note treated as equity for U.S. tax purposes.

## SEC filing metadata
- accession: 0001140361-24-006732
- form_type: 8-K
- cik: 0001838821
- company_name: ARYA Sciences Acquisition Corp IV
- filed_at: 2024-02-09T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1838821/000114036124006732/0001140361-24-006732-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1838821/000114036124006732/ny20020899x2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-006732
- JSON: https://secwatch.observer/filing/0001140361-24-006732.json
- Plain text: https://secwatch.observer/filing/0001140361-24-006732.txt

## Key facts
- Debt Financings
  ARYA Sciences Acquisition Corp IV incurred convertible notes of $1,000,000 with ARYA Sciences Holdings IV at no interest maturing on the effective date of an initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.
  - Instrument: convertible notes
  - Principal: $1,000,000
  - Counterparty: ARYA Sciences Holdings IV
  - Rate: no interest
  - Maturity: on the effective date of an initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination
  - Event: incurrence
  source text: On February 8, 2024, ARYA Sciences Acquisition Corp IV (the “Company”) issued an unsecured convertible promissory note (the “Fourth Promissory Note”) to ARYA Sciences Holdings IV (the “Sponsor”), pursuant to which the Company may borrow $1,000,000 (the “Working Capital Loan”) from the Sponsor for general corporate purposes
  evidence_url: https://www.sec.gov/Archives/edgar/data/1838821/000114036124006732/0001140361-24-006732-index.htm
- Material Agreements
  ARYA Sciences Acquisition Corp IV entered into Fourth Promissory Note with ARYA Sciences Holdings IV (the Sponsor) valued at $1,000,000 (effective 2024-02-08).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: ARYA Sciences Holdings IV (the Sponsor)
  - Value: $1,000,000
  - Effective: 2024-02-08
  source text: On February 8, 2024, ARYA Sciences Acquisition Corp IV (the "Company") issued an unsecured convertible promissory note (the "Fourth Promissory Note") to ARYA Sciences Holdings IV (the "Sponsor"), pursuant to which the Company may borrow $1,000,000 (the "Working Capital Loan") from the Sponsor for general corporate purposes and the funding of the deposits required to be made into the Company's trust account in connection with the monthly extensions of the time period during which the Company may consummate a Business Combination
  evidence_url: https://www.sec.gov/Archives/edgar/data/1838821/000114036124006732/0001140361-24-006732-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.